公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2022 | Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer: Updated results from the phase 3 COSMIC-311 trial | Brose, Marcia S; Robinson, Bruce G; Sherman, Steven I; Jarzab, Barbara; CHIA-CHI LIN ; Vaisman, Fernanda; Hoff, Ana O; Hitre, Erika; Bowles, Daniel W; Sen, Suvajit; Oliver, Jennifer W; Banerjee, Kamalika; Keam, Bhumsuk; Capdevila, Jaume | Cancer | 14 | | |
2021 | Cabozantinib for radioiodine-refractory differentiated thyroid cancer (COSMIC-311): a randomised, double-blind, placebo-controlled, phase 3 trial | Brose M.S.; Robinson B.; Sherman S.I.; Krajewska J.; CHIA-CHI LIN ; Vaisman F.; Hoff A.O.; Hitre E.; Bowles D.W.; Hernando J.; Faoro L.; Banerjee K.; Oliver J.W.; Keam B.; Capdevila J. | The Lancet Oncology | 127 | 101 | |
2013 | Cabozantinib in patients with advanced prostate cancer: Results of a phase II randomized discontinuation trial | Smith D.C.; Smith M.R.; Sweeney C.; Elfiky A.A.; Logothetis C.; Corn P.G.; Vogelzang N.J.; Small E.J.; Harzstark A.L.; Gordon M.S.; Vaishampayan U.N.; Haas N.B.; Spira A.I.; Lara Jr. P.N.; CHIA-CHI LIN ; Srinivas S.; Sella A.; Sch?ffski P.; Scheffold C.; Weitzman A.L.; Hussain M. | Journal of Clinical Oncology | 377 | 346 | |
2013 | Case report | CHIA-CHI LIN ; JANN-YUAN WANG ; YEONG-SHIAU PU | Journal of Clinical Oncology | 6 | 7 | |
2019 | Challenges of the phase I drug development in non-small cell lung cancer | CHIA-CHI LIN | Chinese Clinical Oncology | 7 | 8 | |
2004 | Changing trends of prostate cancer in Asia | YEONG-SHIAU PU ; Chiang H.-S.; CHIA-CHI LIN ; CHAO-YUAN HUANG ; KUO-HOW HUANG ; Chen J. | Aging Male | 103 | 0 | |
2004 | Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide | Hour T.-C.; CHAO-YUAN HUANG ; CHIA-CHI LIN ; Chen J.; Guan J.-Y.; Lee J.-M.; YEONG-SHIAU PU | Anti-Cancer Drugs | 24 | 23 | |
2010 | Chemotherapy response in East Asian non-small cell lung cancer patients harboring wild-type or activating mutation of epidermal growth factor receptors | CHIA-CHI LIN ; Hsu H.-H.; Sun C.-T.; JIN-YUAN SHIH ; ZHONG-ZHE LIN ; CHONG-JEN YU ; Chen G.G.; Hsin M.K.Y.; Lam K.C.; Leung L.; CHIH-HSIN YANG ; Mok T. | Journal of Thoracic Oncology | 26 | 22 | |
2014 | Cisplatin-based combination chemotherapy in septuagenarians with metastatic urothelial cancer | Galsky M.D.; Krege S.; CHIA-CHI LIN ; Hahn N.; Ecke T.H.; Moshier E.; Sonpavde G.; Godbold J.; Oh W.K.; Bamias A. | Urologic Oncology: Seminars and Original Investigations | 22 | 7 | |
2021 | Clinical development of colony-stimulating factor 1 receptor (Csf1r) inhibitors | CHIA-CHI LIN | Journal of Immunotherapy and Precision Oncology | 21 | 0 | |
2022 | Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens | WEI-LI MA ; CHIA-CHI LIN ; FENG-MING HSU ; JANG-MING LEE ; JIN-SHING CHEN ; YEN-LIN HUANG ; YIH-LEONG CHANG ; Chang, Chin-Hao; CHIH-HSIN YANG | Cancer medicine | 3 | 2 | |
2019 | Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective Study | WEI-LI MA ; CHIA-CHI LIN ; FENG-MING HSU ; JANG-MING LEE ; JIN-SHING CHEN ; MIN-SHU HSIEH ; YIH-LEONG CHANG ; Chao Y.-T.; Chang C.-H.; CHIH-HSIN YANG | Clinical Lung Cancer | 9 | 9 | |
2024 | Clinical practice consensus for the diagnosis and management of melanoma in Taiwan | Wu, Chiao-En; YI-HUA LIAO ; Wu, Cheng-Lin; RUOH-FANG YEN ; CHIA-CHI LIN ; Yang, Muh-Hwa; Yen, Chueh-Chuan; Su, Wu-Chou; Yen, Chia-Jui; Chang, Yi-Fang; Wu, Ming-Fang; Yang, Youngsen; Lin, Chen-Yuan; Yang, Wen-Chi; Wang, Hui-Ching; Li, Cheng-Yuan; Ho, Yin-Yu; Chang, Yao-Yu; Wu, Chieh-Shan; Hsu, Hsiu-Cheng; Chen, Kuang-Hua; Huang, Yenlin; Chen, Chih-Jung; Chuang, Pei-Ju; Lai, Yung-Chi; Huang, Yu-Yi; Tseng, Neng-Chuan; Huang, Yi-Ting; CHIA-YU CHU ; Wen-Cheng Chang, John | Journal of the Formosan Medical Association = Taiwan yi zhi | 2 | 0 | |
2022 | Co-Targeting of MDM2 and CDK4/6 with Siremadlin and Ribociclib for the Treatment of Patients with Well-Differentiated or Dedifferentiated Liposarcoma: Results from a Proof-of-Concept, Phase Ib Study | Abdul Razak, Albiruni R; Bauer, Sebastian; Suarez, Cristina; CHIA-CHI LIN ; Quek, Richard; Hütter-Krönke, Marie Luise; Cubedo, Ricardo; Ferretti, Stephane; Guerreiro, Nelson; Jullion, Astrid; Orlando, Elena J; Clementi, Giorgia; Sand Dejmek, Janna; Halilovic, Ensar; Fabre, Claire; Blay, Jean-Yves; Italiano, Antoine | Clinical cancer research : an official journal of the American Association for Cancer Research | 19 | | |
2002 | Comparison of bone marrow studies with blood culture for etiological diagnosis of disseminated mycobacterial and fungal infection in patients with acquired immunodeficiency syndrome | Ker C.-C.; CHIEN-CHING HUNG ; Huang S.-Y.; Chen M.-Y.; SZU-MIN HSIEH ; CHIA-CHI LIN ; SHAN-CHWEN CHANG ; KWEN-TAY LUH | Journal of Microbiology, Immunology and Infection | 30 | 0 | |
2016 | Comparison of skin toxic effects associated with gefitinib, erlotinib, or afatinib treatment for non-small cell lung cancer | Chen, Kai-Lung; CHIA-CHI LIN ; YUNG-TSU CHO ; Yang, Che-Wen; YI-SHUAN SHEEN ; Tsai, Hsiao-En; CHIA-YU CHU | JAMA Dermatology | 29 | 20 | |
2006 | Complete response of urothelial carcinoma to chemotherapy in renal allograft recipients: A two-case study | CHIA-CHI LIN ; CHIH-HUNG HSU ; YEONG-SHIAU PU | Anticancer Research | 0 | 0 | |
2007 | Concurrent chemoradiotherapy with twice weekly paclitaxel and cisplatin followed by esophagectomy for locally advanced esophageal cancer | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHIA-HSIEN CHENG ; HSIU-PO WANG ; JANG-MING LEE ; KUN-HUEI YEH ; CHIH-HSIN YANG ; Lin J.-T.; ANN-LII CHENG ; Lee Y.-C. | Annals of Oncology | 39 | 36 | |
2022 | Correction to: A Phase 1 Study of Sapanisertib (TAK-228) in East Asian Patients with Advanced Nonhematological Malignancies | Shimizu, Toshio; Kuboki, Yasutoshi; CHIA-CHI LIN ; Yonemori, Kan; Yanai, Tomoko; Faller, Douglas V; Dobler, Lwona; Gupta, Neeraj; Sedarati, Farhad; Kim, Kyu-Pyo | Targeted oncology | 0 | 0 | |
2010 | Cross-cultural adaptation and validation of the Quebec User Evaluation of Satisfaction with Assistive Technology (QUEST 2.0): The development of the Taiwanese version | HUI-FEN MAO ; Chen, W.-Y.; Yao, G.; SHEAU-LING HUANG ; CHIA-CHI LIN ; KAI-PING GRACE YAO | Clinical Rehabilitation | 29 | 26 | |